FDA Inspection 1241204 — Maria Alejandra Gracia Villamil, MD.
The FDA completed an inspection of Maria Alejandra Gracia Villamil, MD. on May 31, 2024 in Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 31, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Buenos Aires (Argentina)
Additional Details
Clinical Investigator (CI)